Vikas Madan

Also affiliated with National University Cancer Institute, Singapore, Experimental Drug Development Centre

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas”.

Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas

Cellular and Molecular Life Sciences(2020)10.1007/s00018-020-03620-w

N/A

0DataRank · unranked

13 citations

Aishvaryaa Prabhu, Pushkar Dakle, Elina Pathak, Vikas Madan, Deepika Kanojia +7 more

Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)

Nature Communications(2023)10.1038/s41467-023-37633-3

N/A

0DataRank · unranked

15 citations

Aishvaryaa Prabhu, Galen Tieo, Syed Moiz Ahmed, Pushkar Dakle, Wai Khang Yong +9 more